about
Glaceum
CEOÀÇ Ã¶ÇÐ
ºñÀü°ú ¹Ì¼Ç
¿¬Çõ
¿¬¶ôó/¿À½Ã´Â±æ
Science
¹ÌÅäÄܵ帮¾Æ
´ë»çÁúȯ
ÅðÇ༺³úÁúȯ
¸Á¸·Áúȯ
Pipeline
ÀÓ»ó´Ü°è
IR
°øÁö»çÇ×
°ø½ÃÁ¤º¸
ÀÚ·á½Ç
HR
»ó½Ãä¿ë
Çѱ¹¾î
ENGLISH
Glaceum
CEOÀÇ Ã¶ÇÐ
ºñÀü°ú ¹Ì¼Ç
¿¬Çõ
¿¬¶ôó/¿À½Ã´Â±æ
Science
¹ÌÅäÄܵ帮¾Æ
´ë»çÁúȯ
ÅðÇ༺³úÁúȯ
¸Á¸·Áúȯ
Pipeline
ÀÓ»ó´Ü°è
IR
°øÁö»çÇ×
°ø½ÃÁ¤º¸
ÀÚ·á½Ç
HR
»ó½Ãä¿ë
Çѱ¹¾î
English
IR
ÀÚ·á½Ç
Á¦¸ñ
Safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of vutiglabridin...- CTS
ÀÛ¼ºÀÏÀÚ
2022-10-14
Safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of vutiglabridin: A first-in-class, first-in-human study
COPYRIGHT GLACEUM INC. ALL RIGHTS RESERVED.